Spero Therapeutics, Inc.·4

Aug 30, 4:22 PM ET

JOSEPH TAMARA L 4

4 · Spero Therapeutics, Inc. · Filed Aug 30, 2023

Insider Transaction Report

Form 4
Period: 2023-08-28
JOSEPH TAMARA L
Chief Legal Officer
Transactions
  • Sale

    Common Stock

    2023-08-28$1.26/sh1,854$2,336322,790 total
Footnotes (1)
  • [F1]The reported transaction is a sale of common stock effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted to the Reporting Person on August 26, 2021 pursuant to a "sell to cover" provision included in the RSU Agreement.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4